GM’s 2025 EV production capacity target in doubt after Barra comments

GM’s 2025 EV production capacity target in doubt after Barra comments


GM CEO and Chair Mary Barra speaks during an “EV Day” on March 4, 2020, at the company’s tech and design campus in Warren, Michigan, a suburb of Detroit.

GM

General Motors‘ goal of being capable of producing 1 million all-electric vehicles in North America by the end of 2025 in heavily in doubt, following comments Monday by CEO Mary Barra.

The production capacity target for next year was one of the last EV targets the automaker hadn’t lowered or withdrawn as demand for EVs has not materialized as quickly as many companies such as GM previously expected.

“We won’t get to a million just because the market is not developing, but it will get there,” Barra said Monday at a virtual CNBC CEO Council event. “We’re going to be guided by the customer.”

For more than two years, GM has said it would have production capacity of 1 million in EVs in each China and North America by 2025. Even after it changed or withdrew several EV targets and product plans in the last year, the company continued to say it would install the North American capacity for EVs.

A GM spokesman initially said Barra did not say the company wouldn’t meet the production capacity target. He referenced the question was about producing 1 million EVs, which was not the goal.

The spokesman later said the company would no longer reiterate the EV production capacity plans for 2025. The company has continually said its EV plans will be flexible to meet demand.

More details about the automaker’s EV plans could come when GM reports second-quarter results on July 23.



Source

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Business

Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]

Read More
GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold
Business

GameStop’s Ryan Cohen eyes ‘very big’ consumer megadeal that could increase company’s value tenfold

GameStop wants to acquire a publicly traded consumer company that’s far larger than the video game retailer in a deal that could be “transformational” for the company, CEO Ryan Cohen told CNBC in an interview Friday. “It’s gonna be really big. Really big. Very, very, very big,” Cohen said of the size of the acquisition. […]

Read More
American Express, credit card provider to the wealthy, wants even more high spenders
Business

American Express, credit card provider to the wealthy, wants even more high spenders

American Express announces the new platinum business card. Courtesy: American Express American Express is finding that even for a provider of credit cards to the affluent, it pays to focus on the highest of high rollers. The company recently shifted marketing dollars to its refreshed Platinum card, which carries an $895 annual fee, and away […]

Read More